Pages that link to "Q46580414"

The following pages link to Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated esters (Q46580414):

Displaying 40 items.

• Roles of the Picornaviral 3C Proteinase in the Viral Life Cycle and Host Cells (Q26753001) (← links)
• Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors (Q27648126) (← links)
• Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds (Q27653428) (← links)
• Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease (Q27671833) (← links)
• Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases (Q27683531) (← links)
• Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery (Q34218166) (← links)
• Antiviral drugs specific for coronaviruses in preclinical development (Q34332580) (← links)
• Evaluation of peptide-aldehyde inhibitors using R188I mutant of SARS 3CL protease as a proteolysis-resistant mutant (Q34849521) (← links)
• New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors (Q35620215) (← links)
• An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy. (Q35923992) (← links)
• Potential Broad Spectrum Inhibitors of the Coronavirus 3CLpro: A Virtual Screening and Structure-Based Drug Design Study (Q36403490) (← links)
• Potential antivirals and antiviral strategies against SARS coronavirus infections (Q36441511) (← links)
• Coronaviruses and their therapy (Q36534375) (← links)
• The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease (Q36923117) (← links)
• Long-range cooperative interactions modulate dimerization in SARS 3CLpro. (Q36943869) (← links)
• Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy. (Q37283689) (← links)
• Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors (Q37658853) (← links)
• From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses (Q38135197) (← links)
• Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy (Q39727842) (← links)
• Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. (Q39967863) (← links)
• Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CLPro inhibitors. (Q40068309) (← links)
• Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors (Q42858751) (← links)
• Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease (Q43056416) (← links)
• Mechanistic study of the reaction of thiol-containing enzymes with alpha,beta-unsaturated carbonyl substrates by computation and chemoassays (Q43094227) (← links)
• Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitors for severe acute respiratory syndrome (SARS) 3C-like proteinase (Q45227423) (← links)
• From the similarity analysis of protein cavities to the functional classification of protein families using cavbase (Q45253334) (← links)
• Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease (Q46711512) (← links)
• Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors (Q80849382) (← links)
• Individual and common inhibitors of coronavirus and picornavirus main proteases (Q83232837) (← links)
• Techniques used for the discovery of therapeutic compounds: The case of SARS (Q88187367) (← links)
• Recent discovery and development of inhibitors targeting coronaviruses (Q89477874) (← links)
• Improved synthesis of rupintrivir (Q90670384) (← links)
• Status presens of antiviral drugs and strategies: Part II: RNA VIRUSES (EXCEPT RETROVIRUSES) (Q91908893) (← links)
• Drug Development and Medicinal Chemistry Efforts Toward SARS-Coronavirus and Covid-19 Therapeutics (Q93180376) (← links)
• Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19 (Q93190302) (← links)
• Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study (Q93263973) (← links)
• Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease (Q95601929) (← links)
• Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease (Q96431581) (← links)
• The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020 (Q98563452) (← links)
• Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment? (Q99237635) (← links)